Trial intelligence / Profile preview

Becatecarin in Advanced Hepatobiliary Cancers

NCT00005997Phase 2Terminated

Sponsor
Case Comprehensive Cancer Center
Start
Apr 1999
Primary completion
Apr 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of becatecarin in hepatobiliary carcinoma, sponsored by Case Comprehensive Cancer Center. Started Apr 1999; status: terminated.

02

Drugs

becatecarin
03

Conditions

hepatobiliary carcinoma

Beyond the preview

Go deeper on NCT00005997.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005997.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call